NeuroPace NPCE
NASDAQ NPCE
$13.61 -1.03 (-7.04%)
At close: Aug 20, 2026 · 2:15 PM UTC

NeuroPace (NPCE) Net Margin (2020 - 2026)

NeuroPace (NPCE) posted quarterly Net Margin of 99.54% for Q1 2026, down 7044.0% year-over-year from 1.43% in Q1 2025, and down 921.87% quarter-over-quarter from 9.74% in Q4 2025.

NeuroPace (NPCE) Net Margin (2020 - 2026) Analysis & Trends

NeuroPace's Net Margin history runs 7 years deep, the most recent figure standing at 99.54% for Q1 2026.

  • In Q1 2026, Net Margin fell 7044.0% year-over-year to 99.54%; the TTM figure through Mar 2026 stood at 51.75% (down 1926.0% YoY), while the FY2025 annual figure was 36.04%, up 8515.0% from the prior year.
  • Net Margin for Q1 2026 stood at 99.54%, down from 9.74% in the prior quarter.
  • The five-year high for Net Margin was 9.74% in Q4 2025, with the low at 123.58% in Q2 2022.
  • The 5-year median for Net Margin is 49.76% (2024), against an average of 58.63%.
  • The sharpest annual moves came in 2022 and 2023: Net Margin slumped 7308 bps in 2022, then surged 7266 bps in 2023.
  • NeuroPace's Net Margin stood at 86.01% in 2022, then soared by 84 bps to 13.35% in 2023, then slumped by 161 bps to 34.84% in 2024, then surged by 72 bps to 9.74% in 2025, then tumbled by 922 bps to 99.54% in 2026.
  • Business Quant data shows NPCE's Net Margin at 99.54% in Q1 2026, 9.74% in Q4 2025, and 18.22% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 199.61 Bn 194.01 Bn 7.27 Bn 7.37%
2 Stryker 127.81 Bn 124.34 Bn 4.50 Bn 19.37%
3 Medtronic 119.04 Bn 109.82 Bn 6.41 Bn 12.84%
4 Boston Scientific 73.68 Bn 73.14 Bn 3.85 Bn 16.67%
5 Edwards Lifesciences 51.96 Bn 47.71 Bn 1.35 Bn 13.87%
6 Dexcom 34.36 Bn 32.41 Bn 830.00 Mn 19.04%
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn 10.84%
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 6.47%
9 Steris 23.06 Bn 22.58 Bn 684.20 Mn 13.47%
10 NeuroPace 464.84 Mn 413.14 Mn 18.91 Mn -26.98%

Historic Data

Download Data
DateValue
Mar 31, 2026 -99.54%
Dec 31, 2025 -9.74%
Sep 30, 2025 -18.22%
Jun 30, 2025 -93.38%
Mar 31, 2025 -29.10%
Dec 31, 2024 -34.84%
Sep 30, 2024 -27.01%
Jun 30, 2024 -39.82%
Mar 31, 2024 -49.76%
Dec 31, 2023 -13.35%
Sep 30, 2023 -44.88%
Jun 30, 2023 -56.00%
Mar 31, 2023 -66.04%
Dec 31, 2022 -86.01%
Sep 30, 2022 -104.71%
Jun 30, 2022 -123.58%
Mar 31, 2022 -100.74%
Dec 31, 2021 -97.65%
Sep 30, 2021 -76.73%
Jun 30, 2021 -50.50%